Literature DB >> 17368283

A review of the prognostic factors in patients with recurrence after liver resection for hepatocellular carcinoma.

Masaki Kaibori1, Takamichi Saito, Yoichi Matsui, Yoichiro Uchida, Morihiko Ishizaki, Yasuo Kamiyama.   

Abstract

BACKGROUND: Liver transplantation achieves better results when hepatocellular carcinoma fits the Milan criteria. This study investigated predictors of recurrent hepatocellular carcinoma exceeding the Milan criteria.
METHODS: Among 285 patients with hepatocellular carcinoma fitting the Milan criteria who underwent curative resection, 143 patients suffered initial recurrence (92 had tumors fitting the criteria) and 71 patients suffered a second recurrence (40 conforming tumors).
RESULTS: Survival after hepatectomy was significantly worse when initial recurrence was nonconforming. Similarly, survival after initial recurrence was significantly worse when the second recurrence was nonconforming. A preoperative increase of protein induced by vitamin K absence/antagonist II, a tumor diameter of 3 cm or greater, age of 65 years or younger, and intraoperative blood transfusion increased the risk of nonconforming initial recurrence.
CONCLUSIONS: Liver transplantation should be considered initially for younger patients with hepatocellular carcinoma fitting the Milan criteria, larger tumors, and an increase of protein induced by vitamin K absence/antagonist II.

Entities:  

Mesh:

Year:  2007        PMID: 17368283     DOI: 10.1016/j.amjsurg.2006.06.041

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver.

Authors:  Mohamed Abdel-Wahab; Tarek Salah El-Husseiny; Ehab El Hanafy; Mohamed El Shobary; Emad Hamdy
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

2.  Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma.

Authors:  Satoshi Koizumi; Shingo Yamashita; Satoshi Matsumura; Kazuhisa Takeda; Takuya Minagawa; Shinjiro Kobayashi; Taizo Hibi; Masahiro Shinoda; Itaru Endo; Minoru Tanabe; Masakazu Yamamoto; Takehito Otsubo
Journal:  Mol Clin Oncol       Date:  2020-01-10

3.  Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article.

Authors:  Hao Hu; Rong Liu; Xiao Ran Long; Xi Kun Han; Jia Fan; Zhi Ping Yan; Jian Hua Wang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 4.  A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique.

Authors:  Kumar Jayant; Mikael H Sodergren; Isabella Reccia; Tomokazu Kusano; Dimitris Zacharoulis; Duncan Spalding; Madhava Pai; Long R Jiao; Kai Wen Huang
Journal:  Cancers (Basel)       Date:  2018-11-08       Impact factor: 6.639

5.  Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Authors:  Jian-Hong Zhong; Bang-De Xiang; Wen-Feng Gong; Yang Ke; Qin-Guo Mo; Liang Ma; Xing Liu; Le-Qun Li
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

6.  Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Hao Hu; Xi Kun Han; Xiao Ran Long; Jia Fan; Zhi Ping Yan; Jian Hua Wang; Rong Liu
Journal:  Oncotarget       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.